Dr. Jhanelle E. Gray, MD

Dr. Gray practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Gray's NPI, 1376599340, was assigned on May 25, 2006. Dr. Gray graduated from Weill Cornell Medicine in 2001. Dr. Gray holds Florida license ME91405.

Dr. Gray's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Gray's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Gray to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gray practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gray's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gray is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Gray's licenses on file in 2 states: Florida and New York.

Dmand AI lists lung cancer among the conditions Dr. Gray treats.

CMS data shows 55 Medicare services from Dr. Gray across 1 procedure code in 2024, all of them office visits, for 31 Medicare patients. Medicare paid $6,195 for them.

CMS counts 31 Medicare patients who saw Dr. Gray in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gray's median patient age at 72, with 55% women.

In 2024, Dr. Gray wrote 37 Medicare Part D claims for 11 patients. 65% of them were for generic drugs. They cover 4 drugs, with $641,917 in total drug cost. In 2020, CMS named 103 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gray for performance year 2024, reported as part of a group. Dr. Gray accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gray as offering telehealth.

Dmand AI links 136 papers to Dr. Gray, published from 2010 to 2025. 2019 was the busiest year, with 16. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Combined Chemotherapy Protocols. Dr. Gray has published most often in Clin Cancer Res. Dr. Gray's most frequent co-authors are Eric Haura, MD, Alberto A. Chiappori, MD and Scott Joseph Antonia, MD.

Dmand AI links Dr. Gray to 19 clinical trials, 7 of them phase 1 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Neoplasm Metastasis. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 9. Open Payments lists research payments to Dr. Gray that name 2 trials.

CMS Open Payments shows 246 general payments to Dr. Gray from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. AstraZeneca Pharmaceuticals LP paid the most, $56,485. It also lists 14 research payments totaling $19,363 from 2016 to 2025, naming 2 clinical trials.

Dr. Gray graduated from Weill Cornell Medicine in 2001. Dr. Gray is a member of ASCO.

Dr. Gray is in network with 10 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Humana. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.